Wells Fargo & Company Nemaura Medical Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.15 - $0.34 $0 - $1	5 Added 0.12%	4,163 $0
Q3 2023 Nov 13, 2023	BUY	$0.32 - $1.14 $0 - $2	2 Added 0.05%	4,158 $1,000
Q2 2023 Aug 15, 2023	BUY	$0.49 - $0.93 $1 - $3	4 Added 0.1%	4,156 $3,000
Q1 2023 May 12, 2023	BUY	$0.71 - $2.86 $734 - $2,960	1,035 Added 33.21%	4,152 $3,000
Q4 2022 Feb 13, 2023	BUY	$1.72 - $3.13 $1 - $3	1 Added 0.03%	3,117 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.52 - $2.57 $4 - $7	3 Added 0.1%	3,116 $6,000
Q2 2022 Aug 12, 2022	BUY	$2.53 - $4.42 $17 - $30	7 Added 0.23%	3,113 $8,000
Q1 2022 May 16, 2022	BUY	$3.78 - $4.66 $7,749 - $9,553	2,050 Added 194.13%	3,106 $13,000
Q4 2021 Feb 14, 2022	BUY	$4.12 - $6.35 $4,120 - $6,350	1,000 Added 1785.71%	1,056 $5,000
Q2 2021 Aug 16, 2021	SELL	$4.7 - $16.7 $11,016 - $39,144	-2,344 Reduced 97.67%	56 $1,000
Q1 2021 May 13, 2021	SELL	$3.79 - $9.78 $19,025 - $49,095	-5,020 Reduced 67.65%	2,400 $19,000
Q4 2020 Feb 09, 2021	BUY	$3.47 - $4.52 $9,001 - $11,724	2,594 Added 53.75%	7,420 $28,000
Q3 2020 Nov 05, 2020	BUY	$3.55 - $9.99 $5,041 - $14,185	1,420 Added 41.69%	4,826 $17,000
Q2 2020 Aug 13, 2020	BUY	$4.75 - $15.38 $16,178 - $52,384	3,406 New	3,406 $32,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.